| No. |
Cell type |
JCRB No.
|
Cell Name
|
Animal
|
Tissue
|
Profile
|
|
| 1 | genetically-modified cells |
JCRB1489 |
POLZ D2781N |
human |
peripheral blood |
Human cell line derived from B cell leukemia. (MSH+, POLZ low activity, TK+/-) |
|
| 2 | genetically-modified cells |
JCRB1490 |
POLZ L2618M |
human |
peripheral blood |
Human cell line derived from B cell leukemia. (MSH+, POLZ low fidelity, TK+/-) |
|
| 3 | genetically-modified cells |
JCRB1524 |
POLK CD |
human |
peripheral blood |
Human cell line derived from B cell leukemia. (MSH+, POLK catalytically dead, TK+/-) |
|
| 4 | general cells |
JCRB1531 |
MEFs |
mouse |
embryo |
Mouse embryonic fibroblasts (control MEFs to IKK-i-DEF (JCRB1534) and TBK1-DEF (JCRB1535)). |
|
| 5 | genetically-modified cells |
JCRB1544 |
EMC214 |
human |
uterine endometrium |
Immortalized human uterine endometrial gland-derived mesenchymal cell line. |
|
| 6 | genetically-modified cells |
JCRB1572 |
HAdpc-28-E6E7-TERT |
human |
|
Immortalized human adipose tissue-derived mesenchymal stem cells. |
|
| 7 | genetically-modified cells |
JCRB1736 |
293_hSyn1 |
human |
kidney |
293 cell line into which human Syndecan-1 gene has been transfected. |
|
| 8 | general cells |
JCRB1744 |
XYFMGG03D |
human |
blood |
EBV transformed B-cell lymphoblastoid cell line from human XY female. |
|
| 9 | general cells |
JCRB1745 |
XYFMGG23G |
human |
blood |
EBV transformed B-cell lymphoblastoid cell line from human XY female. |
|
| 10 | general cells |
JCRB1748 |
XYFMGG06K |
human |
blood |
EBV transformed B-cell lymphoblastoid cell line from human XY female. |
|
| 11 | general cells |
JCRB1751 |
XYFMGG19M |
human |
blood |
EBV transformed B-cell lymphoblastoid cell line from human XY female. |
|
| 12 | general cells |
JCRB1756 |
XYFMGG04DM |
human |
blood |
EBV transformed B-cell lymphoblastoid cell line from parent of human XY female (XYFMGG04D). |
|
| 13 | general cells |
JCRB1787 |
BALM-9K |
human |
peripheral blood |
B cell leukemia cell line |
|
| 14 | general cells |
JCRB1788 |
BALM-9KL |
human |
peripheral blood |
B cell leukemia cell line |
|
| 15 | general cells |
JCRB1811 |
Mutu I |
human |
blood |
Burkitt lymphoma derived B cell line latently infected with EBV (type I latency) |
|
| 16 | general cells |
JCRB1830 |
NALM-27 |
human |
peripheral bood |
Biphenotypic (B-cell and myeloid cell features) acute leukemia cell line with a Variant Ph Translocation t(9;22;10)(q34;q11;q22). |
|
| 17 | general cells |
JCRB1876 |
HSC-45 |
human |
ascites |
Human signet ring cell gastric carcinoma cell line establised in vitro from ascites. |
|
| 18 | general cells |
JCRB1877 |
NALM-32 |
human |
peripheral bood |
Biphenotypic features carrying myeloperoxidase mRNA and protein with complex Philadelphia (Ph) chromosome, t(9;22;10)(q34;q11;q22), cell line establish from acute leukemia patient. Derived from the same patient as NALM-27, NALM-28, NALM-30, NALM-31. |
|
| 19 | general cells |
JCRB1885 |
HSC-64 |
human |
ascites |
Human gastric carcinoma (poor differentiated adenocarcinoma) cell line establised in vitro from ascites. |
|
If you wish you add additional cell lines to your order, please click the "Additional order" button below.
It will close the current window and allow you to add additional cell lines to your order.
If you are ready to proceed and place your order, please click on the "Order form (SSL)" button below.